The natural history of treated and untreated primary hyperparathyroidism: The parathyroid epidemiology and audit research study

QJM: An International Journal of Medicine

Volumn 104, Issue 6, 2011, Pages 513-521

  Yu, N ^a   Leese, G P ^b   Smith, D ^c   Donnan, P T ^a  

^a Division of Clinical and Population Sciences and Education   (United Kingdom)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

^c UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; PARATHYROID HORMONE;

ADULT; AGED; ARTICLE; CALCIUM BLOOD LEVEL; DISEASE COURSE; DISEASE SEVERITY; FEMALE; FOLLOW UP; HOSPITAL ADMISSION; HUMAN; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PARATHYROID HORMONE BLOOD LEVEL; PARATHYROIDECTOMY; POPULATION RESEARCH; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREATMENT OUTCOME; UNITED KINGDOM; AGE; BLOOD; COHORT ANALYSIS; MEDICAL AUDIT; MIDDLE AGED; RISK FACTOR;

AGE FACTORS; AGED; AGED, 80 AND OVER; CALCIUM; CLINICAL AUDIT; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; HUMANS; HYPERPARATHYROIDISM, PRIMARY; MALE; MIDDLE AGED; PARATHYROID HORMONE; PARATHYROIDECTOMY; RETROSPECTIVE STUDIES; RISK FACTORS; SCOTLAND;

EID: 80052518031     PISSN: 14602725     EISSN: 14602393     Source Type: Journal    
DOI: 10.1093/qjmed/hcq261     Document Type: Article

References (41)

1. Bilezikian JP. The medical management of primary hyperparathyroidism. Ann Intern Med 1982; 96:198-202.
2. Bollerslev J, Jansson S, Mollerup CL, Nordenstrom J, Lundgren E, Torring O, et al. Medical observation, compared with parathyroidectomy, for asymptomatic primary hyperparathyroidism: a prospective, randomized trial. J Clin Endocrinol Metab 2007; 92:1687-92.
3. Khan A. Primary hyperparathyroidism: diagnosis and management. Endocr Pract 1997; 3:22-26.
4. Marcocci C, Pinchera A. Is parathyroidectomy beneficial in patients with mild, asymptomatic primary hyperparathyroidism? Nat Clin Pract Endocrinol Metab 2007; 3:727.
5. Roche NA, Young AE. Role of surgery in mild primary hyperparathyroidism in the elderly. Br J Surg 2000; 87:1640-9.
6. Scholz DA, Purnell DC. Asymptomatic primary hyperparathyroidism. 10-year prospective study. Mayo Clin Proc 1981; 56:473-8.
7. Silverberg SJ, Shane E, Jacobs TP, Siris E, Bilezikian JP. A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery. N Engl J Med 1999; 341:1249-55.
8. Van'T Hoff W, Ballardie FW, Bicknell EJ. Primary hyperparathyroidism: the case for medical management. Br Med J (Clin Res Ed) 1983; 287:1605-8.
9. Harrison BJ, Wheeler MH. Asymptomatic primary hyperparathyroidism. World J Surg 1991; 15:724-9.
10. Harrop JS, Bailey JE, Woodhead JS. Incidence of hypercalcaemia and primary hyperparathyroidism in relation to the biochemical profile. J Clin Pathol 1982; 35:395-400.
11. Rubin MR, Bilezikian JP, McMahon DJ, Jacobs T, Shane E, Siris E, et al. The natural history of primary hyperparathyroidism with or without parathyroid surgery after 15 years. J Clin Endocrinol Metab 2008; 93:3462-70.
12. Silverberg SJ. Natural history of primary hyperparathyroidism. Endocrinol Metab Clin North Am 2000; 29:451-64.
13. Silverberg SJ, Lewiecki EM, Mosekilde L, Peacock M, Rubin MR. Presentation of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. J Clin Endocrinol Metab 2009; 94:351-65.
14. Khan AA, Bilezikian JP, Potts Jr JT The diagnosis and management of asymptomatic primary hyperparathyroidism revisited. J Clin Endocrinol Metab 2009; 94:333-4.
15. Khan A, Grey A, Shoback D. Medical management of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. J Clin Endocrinol Metab 2009; 94:373-81.
16. Eastell R, Arnold A, Brandi ML, Brown EM, D'Amour P, Hanley DA, et al. Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. J Clin Endocrinol Metab 2009; 94:340-50.
17. Bilezikian JP, Khan AA, Potts Jr JT Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop. J Clin Endocrinol Metab 2009; 94:335-9.
18. Yu N, Donnan PT, Murphy MJ, Leese GP. Epidemiology of primary hyperparathyroidism in Tayside, Scotland, UK. Clin Endocrinol 2009; 71:485-93.
19. Yu N, Donnan PT, Flynn RWV, Michael JM, Smith D, Rudman A, et al. Increased mortality and morbidity in mild primary hyperparathyroid patients. Clin Endocrinol 2009; 73:30-4.
20. HIC. Health Informatics Centre, University of Dundee. [http://www.dundee.ac.uk/hic/] Accessed 18 January 2011.
21. Wilson P. Legal issues of data anonymisation in research. Br Med J 2004; 328:1300-1.
22. Liang K, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika 1986; 73:13-22.
23. Dayton C. Model comparisons using information measures. J Mod App Stat Meth 2003; 2:281-92.
24. Ambrogini E, Cetani F, Cianferotti L, Vignali E, Banti C, Viccica G, et al. Surgery or surveillance for mild asymptomatic primary hyperparathyroidism: a prospective, randomized clinical trial. J Clin Endocrinol Metab 2007; 92:3114-21.
25. Rao DS, Phillips ER, Divine GW, Talpos GB. Randomized controlled clinical trial of surgery versus no surgery in patients with mild asymptomatic primary hyperparathyroidism. J Clin Endocrinol Metab 2004; 89:5415-22.
26. Silverberg S, McMahon D, Usesky J, Flischer J, Shane E, Jacobs P, et al. Natural history of untreated primary hyperparathyroidism: bone density after 15 years. J Bone Miner Res 2006; 21:S118(abstract).
27. Bilezikian JP, Potts JT Jr. Asymptomatic primary hyperparathyroidism: new issues and new questions-bridging the past with the future. J Bone Miner Res 2002; 17(Suppl. 2):N57- 67.
28. Bilezikian JP, Potts JT, Jr, Fuleihan Gel H, Kleerekoper M, Neer R, Peacock M, et al. Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century. J Clin Endocrinol Metab 2002; 87:5353-61.
29. Bilezikian JP, Silverberg SJ. Asymptomatic primary hyperparathyroidism. Clinical practice. N Engl J Med 2004; 350:1746-51.
30. Lendel I, Horwith M. An update from the latest workshop on asymptomatic primary hyperparathyroidism. Otolaryngol Clin North Am 2004; 37:737-49,viii.
31. Chan AK, Duh QY, Katz MH, Siperstein AE, Clark OH. Clinical manifestations of primary hyperparathyroidism before and after parathyroidectomy. A case-control study. Ann Surg 1995; 222:402-12, discussion 412-04.
32. Udelsman R, Pasieka JL, Sturgeon C, Young JE, Clark OH. Surgery for asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. J Clin Endocrinol Metab 2009; 94:366-72.
33. Walgenbach S, Hommel G, Junginger T. Outcome after surgery for primary hyperparathyroidism: ten-year prospective follow-up study. World J Surg 2000; 24:564-9, discussion 569-70.
34. Bollerslev J, Rosen T, Mollerup CL, Nordenstrom J, Baranowski M, Franco C, et al. Effect of surgery on cardiovascular risk factors in mild primary hyperparathyroidism. J Clin Endocrinol Metab 2009; 94:2255-61.
35. Eigelberger MS, Cheah WK, Ituarte PH, Streja L, Duh QY, Clark OH. The NIH criteria for parathyroidectomy in asymptomatic primary hyperparathyroidism: are they too limited? Ann Surg 2004; 239:528-35.
36. Sejean K, Calmus S, Durand-Zaleski I, Bonnichon P, Thomopoulos P, Cormier C, et al. Surgery versus medical follow-up in patients with asymptomatic primary hyperparathyroidism: a decision analysis. Eur J Endocrinol 2005; 153:915-27.
37. Stefenelli T, Mayr H, Bergler-Klein J, Globits S, Woloszczuk W, Niederle B. Primary hyperparathyroidism: incidence of cardiac abnormalities and partial reversibility after successful parathyroidectomy. Am J Med 1993; 95:197-202.
38. Udelsman R. Six hundred fifty-six consecutive explorations for primary hyperparathyroidism. Ann Surg 2002; 235:665-70, discussion 670-662.
39. Coker LH, Rorie K, Cantley L, Kirkland K, Stump D, Burbank N, et al. Primary hyperparathyroidism, cognition, and health-related quality of life. Ann Surg 2005; 242:642-50.
40. Mihai R, Wass JA, Sadler GP. Asymptomatic hyperparathyroidism- need for multicentre studies. Clin Endocrinol 2008; 68:155-64.
41. Quiros RM, Alef MJ, Wilhelm SM, Djuricin G, Loviscek K, Prinz RA. Health-related quality of life in hyperparathyroidism measurably improves after parathyroidectomy. Surgery 2003; 134:675-81, discussion 681-73.